Risk in the use of antibiotics during pregnancy.

  • María Auxiliadora López Zambrano Universidad Laica Eloy Alfaro de Manabí, ULEAM-Ecuador.
  • Mercedes Jacqueline Delgado Carrillo Universidad Laica Eloy Alfaro de Manabí, ULEAM-Ecuador.
  • Luis Enrique González Zúñiga Universidad Laica Eloy Alfaro de Manabí, ULEAM-Ecuador.
  • Carlos Eduardo Morales Villavicencio Universidad Laica Eloy Alfaro de Manabí, ULEAM-Ecuador.
Keywords: Infections, pregnancy, antimicrobial, pharmacokinetic, teratogenic

Abstract

Antimicrobials are medications often used in the treatment of infections in pregnant women. During pregnancy physiological changes occur in women; the pharmacokinetic changes that occur during pregnancy may alter the pharmacological effects, and the possible teratogenic risk and toxicity of the medicinal products in the embryo and fetus must also be taken into account. The use of antibiotics during pregnancy is a frequent circumstance, which requires a correct knowledge of both the properties of the drug, as well as its indications, as well as the characteristics of the people to whom it is prescribed and the stages of gestation and lactation whose differential characteristics require special considerations.

References

Abad FJ, Pons J, Micó M, Casterá DE, Bellés MD, Sánchez A. (2005). Categorías de riesgo de los medicamentos utilizados durante el embarazo: Guía rápida de consulta. FAP 3: 49-61

Cabañas M. et al., (2011). Obstetricia y ginecología. Recuperado de: https://www.sefh.es/bibliotecavirtual/fhtomo2/CAP09.pdf

Hernández Aguilar M. (2019). Uso de antibióticos y lactancia materna. Centro de salud Fuente de San Luis, Valencia. REV. Quimioter 22 (4): 180-185.

Kenyon S, Pike K, Jones D., Brocklehurst P, Marlow N, Salt A, et al. (2008). Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet; 372:1319–27.

Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. (2001) Broadspectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet; 357:989–94.

King CT, Rogers PD, Cleary JD, Chapman SW. (1998). Antifungal therapy during pregnancy. Clin Infect Dis; 27:1151–60.

Ministerio de Salud Pública del Ecuador, (2008). Plan Nacional de reducción de la muerte materna y neonatal. Disponible en: http://observatoriointernacional.com/wp-content/uploads/2014/09/Plan-Nacional-de-Reducci%C3%B3n-Acelerada-de-la-Mortalidad-Materna-y-Neonatal-2008.pdf

Ministerio de Salud Pública del Ecuador, (2016). Infección de vías urinarias en el embarazo. Guía de práctica clínica (GPC). Quito-Ecuador: Dirección Nacional de Normalización.

Nahum GG, Uhl K, Kennedy DL. (2006). Antibiotic use in pregnancy and lactation. What is and is not known about teratogenic and toxic risks. Obstet Gynecol. 107:1120–38.

Pérez JA. (2006). Fármacos en el embarazo y la lactancia. En: Espinas E. Guía de Actuación en Atención Primaria. Ed. semFYC. 3ª edición. Barcelona. pg 1343-1356

Puig-Barbera J. (2004). Vacunas y embarazo (I): vacunas indicadas en mujeres embarazadas. Aten Primaria. 33: 38-43

Reali A, Ximenes A, Cuzzolin L, Fanos V. (2005). Antibiotic therapy in pregnancy and lactation. J Chemother. 17:123–30.

Savioli L, Crompton DW, Neira M. (2003). Use of anthelminthic drugs during pregnancy. Am J Obstet Gynecol. 188:5–6.

Sturpe D, Alperovitz K. (2008). Pregnancy and lactation: Therapic considerations. Chisholm- Burns M et al. Pharmacotherapy: principles & practice. Ed. McGraw Hill. pg. 721-736

Tanaka T, Nakajima K, Murashima A, Garcı´a-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009; 181:55–8.

Vallano A. y Arnau J. (2009). Enfermedades infecciosas y Microbiología Clínica. Enferm Infecc Microbiol Clín; 27(9): 536-542. Disponible en: https://www.sefh.es/sefhdescargas/archivos/AntimicrobianosyEmbarazoSEMIC2009.pdf http://instituciones.msp.gob.ec/documentos/Guias/Guia_infeccion_v_u.pdf

Vera C., (2015). Uso de fármacos en el embarazo. Revista Médica La Paz vol. 21, N.2. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582015000200010

Vilaseca J, Espinas J. (2007). Guía Terapéutica en Atención Primaria basada en la evidencia. Ed. semFYC. 3ª edición. Barcelona.

Ward SA, Sevene EJP, Hasting IM, Nosten F, McGready R. (2007). Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis. 7: 136–44.

Yankowitz J. (2008). Drugs in pregnancy. Gibbs R et al. Danforth’s Obstetrics and Gynecology. 10 Th. Edition. Lippincott Williams & Wilkins. pg 122-136.

Published
2020-04-01